Showing 1 - 20 results of 30 for search 'J.H. Frederik Falkenburg', query time: 0.06s
Refine Results
-
1
-
2
-
3
Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia. by Susanne Badura, Tamara Tesanovic, Heike Pfeifer, Sylvia Wystub, Bart A Nijmeijer, Marcus Liebermann, J H Frederik Falkenburg, Martin Ruthardt, Oliver G Ottmann
Published 2013-01-01
Article -
4
Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction by Wesley Huisman, Wesley Huisman, Didier A. T. Leboux, Lieve E. van der Maarel, Lois Hageman, Derk Amsen, J. H. Frederik Falkenburg, Inge Jedema
Published 2021-03-01
Article -
5
Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo by Soley Thordardottir, Nicolaas Schaap, Elja Louer, Michel G. D. Kester, J. H. Frederik Falkenburg, Joop Jansen, Timothy R. D. Radstake, Willemijn Hobo, Harry Dolstra
Published 2017-03-01
Article -
6
Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence by Els P. van Hees, Laura T. Morton, Dennis F. G. Remst, Anne K. Wouters, Astrid Van den Eynde, J. H. Frederik Falkenburg, Mirjam H.M. Heemskerk
Published 2024-04-01
Article -
7
Mass cytometric analysis unveils a disease-specific immune cell network in the bone marrow in acquired aplastic anemia by Emma S. Pool, Yvonne Kooy-Winkelaar, Vincent van Unen, Vincent van Unen, J.H. Frederik Falkenburg, Frits Koning, Mirjam H. M. Heemskerk, Jennifer M-L. Tjon
Published 2023-11-01
Article -
8
Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals by Wesley Huisman, Wesley Huisman, Lois Hageman, Didier A. T. Leboux, Alexandra Khmelevskaya, Grigory A. Efimov, Marthe C. J. Roex, Derk Amsen, J. H. Frederik Falkenburg, Inge Jedema
Published 2022-03-01
Article -
9
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion by Miranda H Meeuwsen, Laura T Morton, Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst, Marleen M van Loenen, J H Frederik Falkenburg, Mirjam H M Heemskerk
Published 2022-03-01
Article -
10
High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations. by Pleun Hombrink, Sine R Hadrup, Arne Bakker, Michel G D Kester, J H Frederik Falkenburg, Peter A von dem Borne, Ton N M Schumacher, Mirjam H M Heemskerk
Published 2011-01-01
Article -
11
Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation by Thuja Meurer, Esteban Arrieta-Bolaños, Maximilian Metzing, Mona-May Langer, Peter van Balen, J. H. Frederik Falkenburg, Dietrich W. Beelen, Peter A. Horn, Katharina Fleischhauer, Katharina Fleischhauer, Pietro Crivello
Published 2018-10-01
Article -
12
A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR. by Kelly Broen, Henriette Levenga, Johanna Vos, Kees van Bergen, Hanny Fredrix, Annelies Greupink-Draaisma, Michel Kester, J H Frederik Falkenburg, Pieter de Mulder, Theo de Witte, Marieke Griffioen, Harry Dolstra
Published 2011-01-01
Article -
13
Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential by Rosa A. van Amerongen, Laura T. Morton, Umesh G. Chaudhari, Dennis F.G. Remst, Renate S. Hagedoorn, Cathelijne W. van den Berg, Christian Freund, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
Published 2023-03-01
Article -
14
Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation. by Mark G J de Boer, Hetty Jolink, Constantijn J M Halkes, Pim L J van der Heiden, Dennis Kremer, J H Frederik Falkenburg, Esther van de Vosse, Jaap T van Dissel
Published 2011-01-01
Article -
15
Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data. by Paul M Armistead, Shoudan Liang, Hua Li, Sijie Lu, Cornelis A M Van Bergen, Gheath Alatrash, Lisa St John, Sally A Hunsucker, Stefanie Sarantopoulos, J H Frederik Falkenburg, Jeffrey J Molldrem
Published 2011-01-01
Article -
16
Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure by Tassilo L. A. Wachsmann, Anne K. Wouters, Dennis F. G. Remst, Renate S. Hagedoorn, Miranda H. Meeuwsen, Eline van Diest, Jeanette Leusen, Jürgen Kuball, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk
Published 2022-12-01
Article -
17
Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity by Aicha Laghmouchi, Michel G. D. Kester, Conny Hoogstraten, Lois Hageman, Wendy de Klerk, Wesley Huisman, Eva A. S. Koster, Arnoud H. de Ru, Peter van Balen, Sebastian Klobuch, Peter A. van Veelen, J. H. Frederik Falkenburg, Inge Jedema
Published 2022-02-01
Article -
18
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy by Charlotte M. Mousset, Willemijn Hobo, Yun Ji, Hanny Fredrix, Valeria De Giorgi, Robert D. Allison, Michel G. D. Kester, J. H. Frederik Falkenburg, Nicolaas P. M. Schaap, Joop H. Jansen, Luca Gattinoni, Harry Dolstra, Anniek B. van der Waart
Published 2018-10-01
Article -
19
Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase by Anita N. Kremer, Judith Bausenwein, Ellie Lurvink, Andreas E. Kremer, Caroline E. Rutten, Cornelis A. M. van Bergen, Sascha Kretschmann, Edith van der Meijden, Maria W. Honders, Daniela Mazzeo, Colin Watts, Andreas Mackensen, J. H. Frederik Falkenburg, Marieke Griffioen
Published 2020-03-01
Article -
20
Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation by Eva A. S. Koster, Peter A. von dem Borne, Peter van Balen, Erik W. A. Marijt, Jennifer M. L. Tjon, Tjeerd J. F. Snijders, Daniëlle van Lammeren, Hendrik Veelken, J. H. Frederik Falkenburg, Constantijn J. M. Halkes, Liesbeth C. de Wreede
Published 2024-03-01
Article